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Abstract
Background: Breast cancer is the most frequent malignant tumour to metastasize into the
gastrointestinal tract in female and is second only to malignant melanoma. Nevertheless
gastrointestinal metastases arising from breast cancer are quite rare. The upper gastrointestinal
tract is more frequently involved and lobular infiltrating carcinoma has a greater predilection
compared to the ductal type.
Case presentation: The authors describe the case of a 70 years old woman with a preoperative
diagnosis of gastric undifferentiated medullary – type carcinoma, which was the first manifestation
of an occult breast carcinoma. The primary site of carcinoma was identified with the use of a panel
of selected immunohistochemical markers.
Conclusion: Our goal in this case report is to increase the awareness of surgeons and clinicians
to rule out the possibility of mammary origin in circumstance of gastric cancer occurring in female,
even in patients without a previous or concurrent history of breast carcinoma. Although not a
particularly common event, it is, nevertheless, reported in the literature. The differentiation
between primary gastric carcinoma and metastatic breast carcinoma is essential for planning the
correct therapeutic approach, in order to avoid the patient unnecessary surgery.
Background
Breast cancer is the most frequent malignant tumour
among women. Although breast carcinoma is after malig-
nant melanoma the most commont primary tumour
metastasizing to the gastrointestinal tract, mainly the
stomach [1-4], such metastases occur only in 4–18% of
patients [4].
Gastric metastases have been recognised in 6% of patients
with disseminated breast cancer [1] and moreover the
stomach may be the initial site of presentation [5,6].
Mammary malignant tumours show a distinctive systemic
metastatic pattern. Ductal breast carcinoma is compli-
cated by hepatic, lung and brain metastases, while upper
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gastrointestinal tract metastases are more often linked to
lobular carcinoma [3,6,7].
The Authors describe the case of a 70-year-old woman
with a pre-operative diagnosis of gastric undifferentiated
medullary-type carcinoma, which was the first manifesta-
tion of an "occult" breast carcinoma.
Case presentation
A 70-year-old apparently healthy woman with no obvious
clinical history was admitted to medical examination in
other Hospital. She had past history of generic dyspeptic
symptoms, such as nausea and epigastric pain for last 10
years, in the last three months she had reported frequent
episodes of vomiting and a weight loss of 8 Kg. Therefore
she underwent an esophagogastroduodenoscopy, which
demonstrated a widely hyperaemic gastric mucosa, with a
nodular appearance of the fundus and corpus and antral
hypertrophic plicae. The pylorus and duodenum looked
quite normal. Several superficial biopsies of the gastric
corpus were performed and in that contest the histology
in association with a routined immunohistochemical
analysis of the specimens took to the diagnosis of an
"undifferentiated medullary type gastric carcinoma with
focal neuroendocrine differentiation".
CT scan did not reveal any abdominal or nodal metas-
tases. With evidence of absence of disease elsewhere, the
patient underwent a total gastrectomy with lymphoad-
enectomy R1 and a mechanical T-L esophago-jejunos-
tomy with a Roux loop technique.
Macroscopically the gastric mucosa of the fundus and cor-
pus looked thinner than normal, with multiple brownish
elevations, 18/18 perigastric lymph nodes resected were
metastatic. Histological sections of the stump were
stained with Hematoxylin-eosin. Immunohistochemistry
using the strepavidin-avidina-biotina technique, was per-
formed with the following antibodies: estrogen receptor
protein (ER) (dilution 1:100 DAKO), progesteron recep-
tor protein (PR) (dilution1:100 DAKO), CA19.9 (dilution
1:50, BioGenex); cytokeratins (CK7, CK20)
(dilution1:100, DAKO); gross cystic disease fluid protein
15 (GCDFP15) (dilution 1:100 Immunomarkers). All sec-
tions were controstained with Carazzi's hematoxylin. His-
tological examination of neoplastic tissue was consistent
with atypical epithelial elements arranged in a single cell
growth pattern, involved widely the entire stomach, also
spreading through the whole thickness of the wall, from
mucosa to perivisceral fat (Figures 1a and 1b).
Cells were monomorphic, with slight nuclear atypia and
poor cytoplasm and sporadically intracytoplasmatic
lumina were visible in few ones (Figure 1c). These archi-
tectural and cytological features can be typically seen in
breast lobular carcinoma too. Immunohistochemistry
showed reactivity for CK7 (Figures 1d and 1e), for ER (Fig-
ures 1f and 1g), PR and GDFP15 (Figure 1i), while CK 20
and CA 19.9 were negative.
It was evident that a complete histological and immuno-
histochemical analysis of the gastric specimens oriented
now to a strongly suspected lesion as a metastasis arising
from the breast. Therefore the patient was therefore con-
tacted in order to investigate further. Mammography dis-
played a non-palpable lesion (max 1 cm in diameter) with
irregular margins, located in the lower outer quarter of the
left breast (Figure 2). Ultrasound examination confirmed
that the lesion was possibly a cancer. Next the diagnostic
stained tissue sections of surgical specimen demonstrated
that it was, in fact, a lobular carcinoma of the breast (Fig-
ures 3a, b, c), with this immunoassaying profile ER + (fig-
ure 3d) (60%); PR + (40%); Ki67: 5%; human epidermal
growth factor receptor 2 (Her-2) (DAKO) negative.
Postoperative hormone therapy was administered to the
patient, who died, however, 10 months later.
Photomicrographs of stomach Figure 1
Photomicrographs of stomach. a)Small monotonous 
cells arranged in single elements crowed in mucosal layer 
(Haematoxylin-eosin original magnification 10×). b) Lenities 
plastic-like invasion of muscular layers (H&E original magnifi-
cation 20×). c) Neoplastic cells with signet ring-like appear-
ance: presence of an admixture of signet ring cells with single 
sharply circumscribed vacuoles and multivacuolated forms 
(hematoxylin-eosin, original magnification 40×). d-e) Neo-
plastic cells show a strong expression for cytokeratin 7 (orig-
inal magnification 20×; 40×). f-g) Tumors cells show diffuse 
and strong nuclear positivity for oestrogenic receptors (orig-
inal magnification 10×; 20×). h) Focus of Neoplatic cells. i) 
Cytoplasmatic positivity for gross cystic disease fluid protein 
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Discussion
Although the diagnosis of undifferentiated gastric carci-
noma with neuroendocrine differentiation had been sug-
gested from the microscopic observation (a scatter
mucosal spread of neoplastic signet ring cells) of biopsy
specimens, and on the basis of the poor clinical history,
the diffuse and strong positivity for ER, PR, CK7 and
GDFP15 as well as the negativity for CA 19.9 and CK20
suggested that the breast was the primary site of the neo-
plasm.
It is also a fact that the surgical examination of the breast
demonstrated the presence of an impalpable mass con-
sistent with an infiltrating lobular carcinoma, whose mor-
phological (Figures 3a, b, c) and immunoistochemical
characteristics of cells were almost identical to those of the
stomach: ER+ (Figure 3d), CK7+/CK20-; GCDFP15+.
In the gastrointestinal tract it is of great value to distin-
guish a primary carcinoma from a metastatic one, in order
to establish a suitable medical therapy in such patients,
avoiding a surgical procedure. Linitis plastica originating
from a metastatic lobular carcinoma of the breast is
responsive to hormone therapy, to chemotherapy or both,
particularly when metastases are positive to ER and PR.
Nevertheless the prognosis is still poor with a median sur-
vival rate of two years following the diagnosis of gastric
lesions [3].
Lobular breast cancer develops more frequently gastroin-
testinal metastasis than ductal carcinoma [6-10].
In 1980 Cormier et al. from the Mayo Clinic [11], first
described linitis plastica as a metastatic lesion of an inva-
sive lobular breast carcinoma. In the early stages metas-
tases appear as a submucosal isolated lesion [2] producing
a plaque-like or nodular or polypoide appearance [4] or
otherwise irregular mucosal surface in the involved area,
which in time, with a more extensive submucosal and
muscular infiltration, looks macroscopically like a gastric
carcinoma or lymphoma. Further because of blood dis-
semination of tumour cells, metastatic elements may dif-
fusely involve all layers of the entire stomach, skipping or
not the mucosa, resulting in a total lack of distensibility
and in rigidity of the gastric wall such as in linitis plastica.
These patterns are also characteristic of metastases from
lobular carcinoma [12].
Interestingly in a model of spreading where neoplastic
cells may often spare the mucosa, preoperative histologi-
cal diagnosis can be very difficult, by reason of endoscopic
biopsies are in many cases superficial and may lead to
false negative results, that is endoscopic biopsy findings
are normal in up to 50% of patients [13]. Furthermore the
radiological appearance of linitis plastica from breast car-
cinoma metastases is quite similar to that of primary gas-
tric cancer [12,13]. The barium swallow usually
demonstrates mural rigidity, with thickening of the gastric
wall.
CT detection of gastric metastases from breast cancer
presents as widespread gastric wall thickening of more
than 1 cm in an adequately distended stomach [14].
Recently Lorimier et al., [15] have reported that ultra-
Photomicorgraphs of breast Figure 3
Photomicorgraphs of breast. a-b) Lobular carcinoma: 
small cells arranged in row and in single cells. (H&E, original 
magnification 20×). c) Lobular carcinoma: neoplastic cells 
with signet ring like appearance with univacuolated introcy-
toplasmatic lumina.(H&E, original magnification 40×). d) Lob-
ular carcinoma: estrogen nuclear expression (original 
expression 40×).
Mammography showed a nodular lesion with irregular mar- gins of 1 cm in diameter, located in the lower outer quarter  of the left breast Figure 2
Mammography showed a nodular lesion with irregu-
lar margins of 1 cm in diameter, located in the lower 
outer quarter of the left breast.World Journal of Surgical Oncology 2008, 6:78 http://www.wjso.com/content/6/1/78
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sonography was effective for visualising linitis plastica in
a small series of patients with gastric metastases secondary
to breast cancer. Gastric cancer and breast metastasis share
almost the same clinical, endoscopic and radiological fea-
tures that do not help much in specifying whether the lin-
itis plastica is primary or secondary.
Moreover, when also endoscopic biopsy was diagnostic, it
is generally known that lobular carcinoma may also con-
tain a large number of signet-ring cells that if combined
with a gastric mucosal spreading pattern, can mean that
the metastatic disease to the stomach once more is almost
indistinguishable from primary gastric linitis plastica
[16]. However it was remarked that breast SRCCs (Signet
Ring Cell Carcinoma) might show some morphologic dif-
ferences from gastric and colon SRCCs, [17]. In fact breast
SRCCs might contain a single, well-circumscribed univac-
uolated intracytoplasmic lumina, with a central eosi-
nophilic inclusion, whereas other SRCCs usually have the
extended, globoid, and optically clear cytoplasmic acid
mucin that pushes nuclei against the cell membrane On
account of these differences might be difficult to detect in
individual cases, and the morphologic similarity of vari-
ous SRCCs on H&E-stained sections, immunohistochem-
ical analysis has a key role in the determination of the
tissue origins of metastatic SRCCs in spite of clinical his-
tory.
In this context the authors proposed an immunohisto-
chemical algorithm, using successfully a panel of selected
antibodies, CK 20, CK 7, ER, PR, and GCDFP15.
CK 20 proves to be particularly positive in gastric, colorec-
tal, pancreatic and in transitional cell carcinomas, while it
is not observed in any carcinomas of the breast [18,19].
CK 7 in contrast is extensively registered in 90% of carci-
nomas of the breast and its expression was also observed
extensively in 50–64% of primary gastric adenocarcino-
mas [20,21]. For that reason CK 7 and CK 20 expression
patterns, are very useful in metastatic lesions of uncertain
origin. About 30% of gastric adenocarcinomas have the
CK7+/CK20+ pattern; 20% are CK7-/CK20+, 10% have
the CK7-/CK20- pattern and only 20% are CK7+/CK20 –
[21-23].
Several studies have shown almost uniform negativity for
ER in primary gastric carcinomas, Japanese authors have
shown that up to 28% of these tumors may be positive,
with a focal weak to moderate staining intensity [24-26].
Nevertheless the localisation and functionality of ER and
PR receptors in tumoral gastric tissue remain unclear.
Many authors have detected significant amounts of oes-
trogen receptor in normal gastric mucosa with lower
amounts in cancer cells. For them this is consistent with
steroid hormones having a protective action, and may
contribute to the sex difference seen in the incidence of
gastric cancer [27]. Recently, a new estrogenic receptor,
called estrogen receptor beta (ER beta) [28], was found
expressed in various tissues, including normal gastrointes-
tinal tract. The expression of ER beta, in stomach adeno-
carcinomas has been investigated, specifically in signet
ring cell adenocarcinomas, together with surrounding
non-cancerous tissues. The effects of estrogen in stomach
cancer, as well as those in normal stomach, may be medi-
ated by ER beta so that the role of ER beta may differ by
the subtype of stomach adenocarcinoma – specifically sig-
net ring cell adenocarcinomas and other ones. Residual
studies evaluated estrogen and progesterone receptors in
gastrointestinal cancers, with conflicting results. They
detected very low levels of receptors in normal and cancer
tissues, suggesting a feature of the tissue rather than a con-
sequence of a malignant process [29].
It's clear that the role of ER or PR in these cancers must still
be elucidated such as if this unusual immunophenotype
might cause a pitfall in gastric biopsy specimens. Further-
more cytoplasmic positivity for gross cystic disease fluid
protein (GCDFP-15) may be also functional to confirm a
mammary origin. Many reports have established that
immunohistochemical detection of GCDFP-15 is a sensi-
tive marker for lobular breast carcinoma and that it is a
convenient addition in the diagnosis of metastatic carci-
noma of suspected breast origin since that it has been
found to be positive in breast cancers and negative in all
primary stomach cancers. However GCDFP-15 has not
been widely studied because of a 90% specificity for breast
tissue, but a sensitivity of only 50% [30,31].
To recap mammary metastasis, as in our own case, may
resemble primary GI carcinomas by radiologic, endo-
scopic, and, particularly, histological methods. So distin-
guishing between metastasis carcinomas of the breast and
a primary gastric adenocarcinoma, especially poorly dif-
ferentiated, diffuse or signet ring cell types, is a distinction
without a difference, if based only on the morphology of
both tumors.
Azzopardi [32] and then Battifora [33] in the past
described a distinctive type of intracytoplasmic vacuole
within tumour cells, characterized by the presence of a
round globule of syalomucin that imparts a "target"
appearance to the cell or by the presence of a single
sharply demarcated intracytoplasmic vacuole, with or
without a central eosinophilic inclusion, which was
termed the "univacuolated lumen type" of signet ring cell.
Battifora contrasted this with a second type of signet ring
cell with "multivacuolated" cytoplasm, termed the "GI
type" and proposed that the former type of cell may be
specific for carcinoma of the breast. In our case, an almostWorld Journal of Surgical Oncology 2008, 6:78 http://www.wjso.com/content/6/1/78
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prevalent component of univacuolated signet ring cells
was observed. Therefore, in our opinion the morphologic
appearance of the tumour cells in accordance of pub-
lished criteria, was not of limited value in distinguishing
metastatic invasive lobular carcinoma from primary gas-
tric carcinomas.
Unfortunately, in many cases diffuse type gastric adeno-
carcinomas and lobular carcinomas of the breast often
overlap their cytomorphologic features, showing a single-
cell growth pattern and a mixture of types of signet-ring
cells [16]. This fact suggests a more confident use of
selected immunohistochemistry approaching to gastroin-
testinal adenocarcinomas, regardless of clinical or histo-
logical evidences, because primary and metastatic
carcinomas of the GI tract have significantly different
treatment and prognosis.
To perform this, we used a panel of antibodies, of differ-
ent antigenic subtypes, that we believed might yield useful
diagnostic information. These included the following
ones that have traditionally been associated with breast
carcinomas: estrogen receptor protein (ER), progesterone
receptor protein (PR), gross cystic disease fluid protein
(GCDFP15), and cytokeratins (CK7).
The reactivity for CK7 and GCDFP15, including hormone
receptor expression, and for contrast, the negativity for
CK20 and CA 19.9, were in this case of great value to dif-
ferentiate an unsuspected lobular carcinoma from a gas-
tric cancer.
Only after a correct diagnosis we were able to initiate the
treatment targeted towards systemic breast cancer.
Patients with linitis plastica from breast cancer metastases
have been known to respond to hormone therapy or
chemotherapy, or both, particularly if the metastases are
strongly positive for oestrogen receptors. Surgery should
be only reserved for palliation in cases of intestinal
obstruction or bleeding. The prognosis of these patients is
still uncertain. Generally gastric metastases reflect a poor
prognosis [3]. In the series by Taal et al. the median sur-
vival from the time of diagnosis of gastric metastases was
almost 2 years; only 6 (22%) of the 27 patients survived
for more than 2 years [13]. On the other hand such a ther-
apeutic approach is more likely to have a profound effect
on survival especially if no other extensive metastases are
present.
Conclusion
We report a rare case of metastatic disease to the stomach
arising from a non palpable lesion of the breast. Unlike
previously reported cases, in which the primary breast
lesion had been well recognised or was clinically evident,
in this our case a breast cancer was found to be the pri-
mary tumour only after that gastrectomy had yet been per-
formed, in a woman with no other pathological history
than a "diagnosed" gastric cancer. Furthermore we
describe a history report that can take away from the truth:
an old female patient with a dyspeptic disorder and with
no clinical signs of unhealthy breast; an esofagogastrodu-
odenoscopy positive, which showed a vastly hyperaemic
gastric mucosa, with nodular appearance of the fundus
and corpus and hypertrophic plicae of antrum; a superfi-
cial biopsy with minimal tissue showing a mucosal
spreading of diffuse monotonous neoplastic cells with sig-
net-ring like appearance. Everything suggested the errone-
ous diagnosis of primary gastric adenocarcinoma.
To avoid a similar situations, we suggest an algorithmic
use of targeted immunohistochemical markers in order to
determine the primary site of gastrointestinal tumours.
Making a primary gastric cancer appear different from a
metastatic one, especially if it is of mammary origin, is a
great challenge for a correct planning of the therapeutic
approach, not only to act on survival but also to spare the
patient unnecessary surgery. The Authors goal is to
increase the awareness on this event among clinicians,
pathologists and surgeons.
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